Physician profile
Amy Kaplan
NPI 1194788356
$328.50
in general payments reported to CMS, 2019-2025
11 companies · $18.31 in 2025
The $18.31 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $15.31 · 2022: $46.93 · 2023: $56.51 · 2024: $42.19 · 2025: $18.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $69.03 | 2019-2023 | Vaxneuvance, M-M-R II, Vaxelis |
| Kaleo, INC. | $43.52 | 2019 | |
| Pfizer INC. | $40.97 | 2019 | |
| Supernus Pharmaceuticals, INC. | $37.09 | 2023-2024 | Qelbree, Qelbree |
| Galderma Laboratories, L.P. | $29.52 | 2019-2023 | Epsolay, Twyneo, Aklief |
| Hologic Sales and Service, LLC | $21.12 | 2024 | Aptima |
| Ironshore Pharmaceuticals INC. | $18.64 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $18.31 | 2025 | Neffy |
| Tris Pharma INC | $17.87 | 2022 | |
| Glaxosmithkline, LLC. | $16.70 | 2019 | |
| Cranial Technologies, INC | $15.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.